{
  "retracted": true,
  "timestamp": 1577664000000,
  "updates": [
    {
      "timestamp": 1591717339149,
      "identifier": {
        "doi": "10.1186/s12935-019-1084-7"
      },
      "type": "retraction"
    }
  ],
  "identifier": {
    "doi": "10.1186/s12935-019-0778-1"
  },
  "journal": "Cancer Cell International",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Retraction Note to: LATS2 overexpression attenuates the therapeutic resistance of liver cancer HepG2 cells to sorafenib‑mediated death via inhibiting the AMPK–Mfn2 signaling pathway"
}
